Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.

The Dow Jones Industrial Average ended Wednesday (June 18) modestly lower following the Federal Reserve’s latest policy ...

Verve Therapeutics remains an early-stage biotech, making the rally purely acquisition-driven, not based on fundamentals.

Given the volatile regional situation, the Kuwaiti Cabinet on Tuesday weighed arrangements and measures made by all minist ...

Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the ...

NASCAR fans have grown accustomed to seeing speed, throttle and braking on broadcasts for years. There has been one measurement, though, that has eluded networks and viewers for years.

Through Friday, Capital One’s COF stock had returned 10.9% for 2025, while Discover shares had returned 16% as investors became more confident the deal would be completed. The KBW Bank Index had ...

What about Nvidia? Instead of momentum, the tech stock has mainly experienced malaise. The Trump administration's export restrictions on artificial intelligence (AI) chips have created a dark ...

Get the annual and quarterly balance sheets for Prime Medicine, Inc. (PRME) including details of assets, liabilities and shareholders’ equity.

Hong Kong has played host to dozens of innovative drug IPOs since opening up the market to such money-losing companies in 2018. In the years that followed, companies peddling everything from ...

That's the psychoactive compound that Mind Medicine -- or MindMed ... shifts it could do quite interesting work. But this is a stock for investors with high risk tolerance only.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...